Molbio Launches EDGE: A Transformative Scale Up Partnership Program for Healthcare Innovation
February 05, 2024
We're thrilled to announce the launch of EDGE, Molbio's innovative scaleup partnership program dedicated to accelerating game-changing healthcare technologies.
EDGE is a two-step journey:
Competitive Cohort Selection: We'll rigorously select high-potential startups and SMEs with groundbreaking solutions in rapid POC for high sensitivity immunodiagnostics and early cancer detection.
High-Touch Engagement & Potential Partnership: Over 12 weeks, selected participants will receive intensive mentorship, resources, and expertise from Molbio's team of seasoned professionals. This culminates in the opportunity to forge co-development, manufacturing, or global sales partnerships with Molbio.
Why join EDGE?
Bridge the Valleys of Death: Overcome critical hurdles in product development, translation, and scaleup with Molbio's guidance and support.
Gain Global Reach: Leverage Molbio's extensive network and expertise to bring your innovation to a worldwide audience.
Make a Real Impact: Contribute to the mission of equitable & accessible healthcare by delivering solutions that truly matter.Read more
Nipah: Kerala gets ICMR approval to conduct Truenat test to detect virus
The Hindu, September 20, 2023
Kerala has been accorded sanction by the Indian Council for Medical Research (ICMR) to use Truenat test to diagnose Nipah. Hospitals with BSL 2 level labs can perform the test. The standard operating procedure for the same will be prepared, Health Minister Veena George has said.Read more
The Role of PCR in early diagnosis of Zika Virus and Chikungunya Amid Monsoon
Financial Express Healthcare.com, July 02, 2023
Zika (ZIKV), Dengue (DENV) and Chikungunya viruses (CHIKV) co-circulate in the same geographical areas during the same seasonal period through the same biting arthropods.Read more
The Importance of rapid testing of Vector-borne Disease During Rainy Season
Financial Express Healthcare.com, July 01, 2023
Vector-borne diseases continue to contribute significantly to the global burden of disease and cause epidemics that disrupt health security and cause wider socioeconomic impacts around the world.Read more
Strengthening TB Diagnosis in Kakamega County through the Roll Out of the Truenat Machine
Centre for Health Solutions, June 28, 2023
On a brighter Thursday morning in March 2023, we set on a journey from Kisumu to Navakholo Sub County Hospital, Kakamega County, one of the beneficiaries of the 38 TB molecular Truenat machines rolled out in the country last year.Read more
PE-Backed Molbio’s Natarajan On Revenue Growth And Why It Isn't Chasing M and As
VCCircle, May 29, 2023
India’s diagnostics sector has always been a sweet spot for investors, and gained further traction from private equity players during the Covid-19 pandemic. Temasek- and Motilal Oswal PE-backed Molbio Diagnostics is no different. Molbio attained a valuation of $1.6 billion last year when Temasek led an $85-million (around Rs 680 crore)…Read more
Molbio joins hands with ShanMukha Innovations
The Navhind Times, May 26, 2023
Molbio will help Shanmukha with the development, manufacturing and commercialisation of the platform, in line with its vision of enabling the availability of futuristic health technologies to the world.Read more
The Healthtech Boom: What Makes A Unicorn
BW Healthcare World, May 03, 2023
“It took almost two decades of research, development and commercialisation efforts to make Truenat the world’s first and only truly pointof-care, multi-disease real-time PCR platform that is completely laboratory independent and that can be deployed in the most remote locations,” says Sriram Natarajan,Director, Molbio Diagnostics. Read more
Molbio collaborates with SigTuple to build next-gen diagnostic testing devices
ET Healthworld.com, April 13, 2023
The aim of the partnership is to bridge this gap and enable most basic tests to be performed in near-patient settings. Both companies are collaborating on the development of AI-powered, battery-operated, portable devices for many diagnostic tests in the fields of haematology, biochemistry, electrochemistry, and others.Read more
Molbio Diagnostics launches Truenat H3N2/H1N1 diagnostic tests
ET Healthworld, April 03, 2023
India is currently seeing a surge in influenza viral infections due to H3N2 and H1N1. Therefore it is of utmost importance to have an early confirmatory diagnosis to initiate rapid disease management efforts for controlling the spread and reducing influenza-related morbidity and mortality, both during seasonal epidemics and pandemics. Read more